Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Perrone
The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Front Cover: The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders (ChemMedChem 13/2019)
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Related publications
Histamine H3 Receptor Inverse Agonist Alleviate Mechanical Allodynia Through the Activation of H1R and H2R in Periaqueductal Gray Matter.
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Effect of Histamine H3 Receptor Agonist on the Chemotherapy-Induced Fatigue in Mice
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Fishing for Histamine H3 Receptor Functions
Acta Physiologica
Physiology
The Histamine Autoreceptor Is a Short Isoform of the H3 Receptor
British Journal of Pharmacology
Pharmacology
Immethridine, Histamine H3-Receptor (H3R) Agonist, Alleviated Experimental Autoimmune Encephalomyelitis via Inhibiting the Function of Dendritic Cells
Oncotarget
Oncology
The Brain H3-Receptor as a Novel Therapeutic Target for Vigilance and Sleep–wake Disorders
Biochemical Pharmacology
Biochemistry
Pharmacology
Enhanced Histaminergic Neurotransmission and Sleep-Wake Alterations, a Study in Histamine H3-Receptor Knock-Out Mice
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Discovery of S-(2-Guanidylethyl)-Isothiourea (VUF 8430) as a Potent Nonimidazole Histamine H4 Receptor Agonist